OVIT Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
Oncovista Innovative Therapies Inc. Stock Analysis OVIT
United States Health Care Nano Cap OncoVista Innovative Therapies, Inc. is a drug development company, which engages in the development and commercialization of targeted cancer therapies. The company is headquartered in San Antonio, Texas. The company went IPO on 2006-01-23. The firm is engaged in developing targeted anticancer therapies by utilizing tumor-associated biomarkers. The firm's product pipeline consists of advanced (Phase II) and early (Phase I) clinical-stage compounds, late preclinical drug candidates and early preclinical leads. The firm's therapeutic strategy is based on targeting the patient's tumors with treatments that will deliver drugs selectively based upon specific biochemical characteristics of the cancer cells comprising the tumor. The firm's products include: Cordycepin (OVI-123) and L-Nucleoside Conjugates (OVI-117). Cordycepin depends upon the presence of a DNA polymerase, known as terminal deoxynucleotidyl transferase (TdT), for its therapeutic activity. OVI-117 is a thymidylate synthase (TS) inhibitor with pharmacological properties, which results in a retention of efficacy and a reduction of toxicity.
Read More OVIT Chart
Oncovista Innovative Therapies Inc vs S&P 500 Comparative Returns
Analysis of OVIT stock performance compared to the broader market (S&P 500) across multiple timeframes.
YTD Performance
- Oncovista Innov... (OVI...) -50%
- S&P 500 8.2%
Oncovista Innov... Underperformed S&P 500 by 58.20%
1Y Performance
- Oncovista Innov... (OVI...) 0%
- S&P 500 17.63%
Oncovista Innov... Underperformed S&P 500 by 17.63%
3Y Performance
- Oncovista Innov... (OVI...) 9900%
- S&P 500 54.54%
Oncovista Innov... Outperformed S&P 500 by 9845.46%
5Y Performance
- Oncovista Innov... (OVI...) -99.33%
- S&P 500 94.73%
Oncovista Innov... Underperformed S&P 500 by 194.06%
Key Statistics of Oncovista Innovative Therapies Inc(OVIT)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
1500.00P/E Ratio (TTM)
-52 Week Range
Market Cap
2400.00Avg. Volume
1500.00Dividend Yield
-Financial Metrics & Statements of Oncovista Innovative Therapies Inc(OVIT)
- Per Share Data
- Ratios
- Statements
No Data Available!
Annual 
Quarterly
No Annual Data Available!
FAQ's
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Alternate Halal Stocks
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
